phosphorylethanolamine has been researched along with Anemia, Iron-Deficiency in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, R | 1 |
| Tkac, I | 1 |
| Unger, EL | 1 |
| Ennis, K | 1 |
| Hurst, A | 1 |
| Schallert, T | 1 |
| Connor, J | 1 |
| Felt, B | 1 |
| Georgieff, MK | 1 |
1 other study available for phosphorylethanolamine and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
Iron supplementation dose for perinatal iron deficiency differentially alters the neurochemistry of the frontal cortex and hippocampus in adult rats.
Topics: Anemia, Iron-Deficiency; Animals; Aspartic Acid; Cognition Disorders; Dietary Supplements; Dipeptide | 2013 |